136 related articles for article (PubMed ID: 9101710)
1. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice.
Deol P; Khuller GK
Biochim Biophys Acta; 1997 Mar; 1334(2-3):161-72. PubMed ID: 9101710
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice.
Deol P; Khuller GK; Joshi K
Antimicrob Agents Chemother; 1997 Jun; 41(6):1211-4. PubMed ID: 9174172
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.
Labana S; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2002 Oct; 20(4):301-4. PubMed ID: 12385689
[TBL] [Abstract][Full Text] [Related]
4. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.
Vyas SP; Kannan ME; Jain S; Mishra V; Singh P
Int J Pharm; 2004 Jan; 269(1):37-49. PubMed ID: 14698575
[TBL] [Abstract][Full Text] [Related]
5. Dual antitubercular drug loaded liposomes for macrophage targeting: development, characterisation,
Shrivastava P; Gautam L; Sharma R; Dube D; Vyas S; Vyas SP
J Microencapsul; 2021 Mar; 38(2):108-123. PubMed ID: 33267623
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
Allen TM; Hansen C
Biochim Biophys Acta; 1991 Sep; 1068(2):133-41. PubMed ID: 1911826
[TBL] [Abstract][Full Text] [Related]
7. Lung specific stealth liposomes as antitubercular drug carriers in guinea pigs.
Pandey R; Sharma S; Khuller GK
Indian J Exp Biol; 2004 Jun; 42(6):562-6. PubMed ID: 15260105
[TBL] [Abstract][Full Text] [Related]
8. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
[TBL] [Abstract][Full Text] [Related]
9. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
Maruyama K; Kennel SJ; Huang L
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles.
Dutt M; Khuller GK
J Antimicrob Chemother; 2001 Jun; 47(6):829-35. PubMed ID: 11389115
[TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
12. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
[TBL] [Abstract][Full Text] [Related]
13. Liposomes and PLG microparticles as sustained release antitubercular drug carriers--an in vitro-in vivo study.
Dutt M; Khuller GK
Int J Antimicrob Agents; 2001 Sep; 18(3):245-52. PubMed ID: 11673037
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice.
Dutt M; Khuller GK
Antimicrob Agents Chemother; 2001 Jan; 45(1):363-6. PubMed ID: 11121000
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution.
Xu Y; Meng H
Artif Cells Nanomed Biotechnol; 2016; 44(1):350-5. PubMed ID: 25162671
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Delivery of Anti-Tubercular Drugs Using Ligand Anchored pH Sensitive Liposomes for the Treatment of Pulmonary Tuberculosis.
Bhardwaj A; Grobler A; Rath G; Goyal AK; Jain AK; Mehta A
Curr Drug Deliv; 2016; 13(6):909-22. PubMed ID: 26718489
[TBL] [Abstract][Full Text] [Related]
17. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).
Maruyama K; Yuda T; Okamoto A; Kojima S; Suginaka A; Iwatsuru M
Biochim Biophys Acta; 1992 Sep; 1128(1):44-9. PubMed ID: 1390877
[TBL] [Abstract][Full Text] [Related]
18. Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes.
Dos Santos N; Mayer LD; Abraham SA; Gallagher RC; Cox KA; Tardi PG; Bally MB
Biochim Biophys Acta; 2002 Apr; 1561(2):188-201. PubMed ID: 11997119
[TBL] [Abstract][Full Text] [Related]
19. Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
Harasym TO; Cullis PR; Bally MB
Cancer Chemother Pharmacol; 1997; 40(4):309-17. PubMed ID: 9225948
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution of EDTA encapsulated within liposomes of varying surface properties.
Jonah MM; Cerny EA; Rahman YE
Biochim Biophys Acta; 1975 Sep; 401(3):336-48. PubMed ID: 810161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
